Suppr超能文献

青少年兴奋剂滥用。

Stimulant misuse among youth.

机构信息

Boston University School of Medicine, 72 E Concord St, Boston, MA 02118, United States.

Division of Adolescent and Young Adult Medicine, Mass General for Children, 175 Cambridge St., 5th Floor, Boston, MA 02114, United States; Department of Pediatrics, Harvard Medical School, 25 Shattuck St., Boston, MA 02115, United States.

出版信息

Curr Probl Pediatr Adolesc Health Care. 2022 Sep;52(9):101265. doi: 10.1016/j.cppeds.2022.101265. Epub 2022 Sep 29.

Abstract

Rates of stimulant use, including misuse of prescription stimulants and use of cocaine and methamphetamine, are rising rapidly among adolescents and young adults ("youth"). Stimulant misuse is associated with overdose, polysubstance use, substance use disorders, and other medical harms. Substance use is often initiated during adolescence and young adulthood, and interventions during these crucial years have the potential to impact the lifetime risk of stimulant use disorder and associated harms. In this narrative review, we review recent data on prescription and illicit stimulant use in youth. We describe the rising contribution of stimulants to polysubstance use involving opioids and other substances and to overdose, as well as ways to minimize harm. We also discuss prescription stimulant misuse, which is especially prevalent among youth relative to other age groups, and the limited evidence on potential pathways from prescription stimulant use to illicit stimulant use. Last, we assess potential strategies for the prevention and treatment of stimulant use disorder in youth.

摘要

兴奋剂的使用频率,包括处方兴奋剂的滥用和可卡因及冰毒的使用,在青少年和年轻人(“青年”)中迅速上升。兴奋剂滥用与过量使用、多物质使用、物质使用障碍和其他医疗危害有关。物质使用通常在青少年和成年早期开始,这些关键时期的干预措施有可能影响一生中兴奋剂使用障碍和相关危害的风险。在这篇叙述性综述中,我们回顾了最近关于青年人群中处方和非法兴奋剂使用的数据。我们描述了兴奋剂在涉及阿片类药物和其他物质的多物质使用以及过量使用中所占比例不断上升的情况,以及如何最大限度地减少危害。我们还讨论了处方兴奋剂的滥用,这在青年人群中比其他年龄组更为普遍,以及关于从处方兴奋剂使用到非法兴奋剂使用的潜在途径的有限证据。最后,我们评估了预防和治疗青年人群中兴奋剂使用障碍的潜在策略。

相似文献

1
Stimulant misuse among youth.
Curr Probl Pediatr Adolesc Health Care. 2022 Sep;52(9):101265. doi: 10.1016/j.cppeds.2022.101265. Epub 2022 Sep 29.
2
Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?
J Child Psychol Psychiatry. 2024 Jan;65(1):100-111. doi: 10.1111/jcpp.13807. Epub 2023 Apr 16.
3
Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.
J Subst Abuse Treat. 2022 Dec;143:108894. doi: 10.1016/j.jsat.2022.108894. Epub 2022 Sep 30.
5
Stimulant Use Disorders.
Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):461-71. doi: 10.1016/j.chc.2016.02.004. Epub 2016 Mar 28.
6
Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years.
J Stud Alcohol Drugs. 2018 Sep;79(5):799-807. doi: 10.15288/jsad.2018.79.799.
7
Nonmedical use of prescription opioids and stimulants among student pharmacists.
J Am Pharm Assoc (2003). 2009 Jul-Aug;49(4):519-28. doi: 10.1331/JAPhA.2009.08027.
8
Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.
Drug Alcohol Depend. 2007 Jul 10;89(2-3):195-205. doi: 10.1016/j.drugalcdep.2006.12.020. Epub 2007 Jan 24.
9
Disparities in Use/Misuse of Specific Illicit and Prescription Drugs among Sexual Minority Adults in a National Sample.
Subst Use Misuse. 2022;57(3):461-471. doi: 10.1080/10826084.2021.2019776. Epub 2022 Jan 22.
10
Signals of increasing co-use of stimulants and opioids from online drug forum data.
Harm Reduct J. 2022 May 25;19(1):51. doi: 10.1186/s12954-022-00628-2.

引用本文的文献

1
Trends in Industry Marketing of Stimulants to Physicians and Advanced Practice Clinicians.
JAMA Pediatr. 2025 Aug 25. doi: 10.1001/jamapediatrics.2025.2811.
2
Opioid and stimulant co-prescribing: our efforts and remaining open questions-authors' reply.
Lancet Reg Health Am. 2025 Apr 29;45:101118. doi: 10.1016/j.lana.2025.101118. eCollection 2025 May.
6
Cocaine reward and reinstatement in adolescent versus adult rodents.
Front Behav Neurosci. 2024 Jan 5;17:1278263. doi: 10.3389/fnbeh.2023.1278263. eCollection 2023.
7
Gender differences in the prevalence of stimulant misuse in the United States: 2015-2019.
Am J Addict. 2024 May;33(3):283-289. doi: 10.1111/ajad.13501. Epub 2023 Nov 4.

本文引用的文献

1
Pharmacotherapy treatment of stimulant use disorder.
Ment Health Clin. 2021 Nov 8;11(6):347-357. doi: 10.9740/mhc.2021.11.347. eCollection 2021 Nov.
2
Socioeconomic Burden of Rising Methamphetamine-Associated Heart Failure Hospitalizations in California From 2008 to 2018.
Circ Cardiovasc Qual Outcomes. 2021 Jul;14(7):e007638. doi: 10.1161/CIRCOUTCOMES.120.007638. Epub 2021 Jul 13.
3
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350. doi: 10.1097/YCO.0000000000000717.
4
Factors associated with crack-cocaine early initiation: a Brazilian multicenter study.
BMC Public Health. 2021 Apr 23;21(1):781. doi: 10.1186/s12889-021-10769-x.
5
Shifts in drug seizures in the United States during the COVID-19 pandemic.
Drug Alcohol Depend. 2021 Apr 1;221:108580. doi: 10.1016/j.drugalcdep.2021.108580. Epub 2021 Mar 2.
6
Bupropion and Naltrexone in Methamphetamine Use Disorder.
N Engl J Med. 2021 Jan 14;384(2):140-153. doi: 10.1056/NEJMoa2020214.
8
Suspected Nonfatal Drug-Related Overdoses Among Youth in the US: 2016-2019.
Pediatrics. 2021 Jan;147(1). doi: 10.1542/peds.2020-003491. Epub 2020 Dec 7.
9
Polysubstance Involvement in Opioid Overdose Deaths in Adolescents and Young Adults, 1999-2018.
JAMA Pediatr. 2021 Feb 1;175(2):194-196. doi: 10.1001/jamapediatrics.2020.5035.
10
Medical, Nonmedical, and Illegal Stimulant Use by Sexual Identity and Gender.
Am J Prev Med. 2020 Nov;59(5):686-696. doi: 10.1016/j.amepre.2020.05.025. Epub 2020 Sep 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验